TrialThe Journal of infectious diseases2016

Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.

Lior Nesher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.